Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Post-finasteride syndrome's existence is uncertain; more research needed.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Finasteride doesn't affect bone density in male rats.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

Transplanting growing hair follicles into scars can help regenerate and improve scar tissue.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Finasteride helps induce ovulation in nonresponder PCOS women.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Testosterone reduces heart damage and inflammation after injury.

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.

Testosterone and finasteride raise insulin and zinc, lower chromium in male rats.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Finasteride doesn't affect ovulation in normal women.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

A postmenopausal woman's high testosterone levels and symptoms improved after removing a tumor from her ovary.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.